Answers are grounded in this paper and cite their sources.
Novel DNA-based biomaterials enhance cancer immunotherapy, suggesting improved outcomes for patients.
DNA-based biomaterials have emerged as powerful platforms for advancing cancer immunotherapy, leveraging their unique programmability, structural precision, and biocompatibility. By enabling rational design at the molecular level, DNA nanostructures, such...
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: